Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I-IIa feasibility and safety study of autologous adipose-derived stem cells for local treatment of tracheoesophageal fistulas
2009-011244-19Phase 2Terminated
- Sponsor
- FIBHULP
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of terazosin in tracheoesophageal fistula (TEF), sponsored by FIBHULP. Primary endpoint: Feasibility and safety. Started Mar 2009; status: terminated.
02
Drugs
terazosin
03
Conditions
tracheoesophageal fistula (TEF)
Beyond the preview
Go deeper on 2009-011244-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011244-19.